Today, biomaterial-based solutions play an important role in clinical applications.

They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.

PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.

 

 

Components of the PANBioRa biomaterial risk assessment system

ANTIBODY TESTING
Patient-specific interactions between biomaterials and the immune system will be assessed using the ground-breaking Mimotope Variation Analysis technology.
ANTIBODY TESTING
BIOMATERIAL TESTING
Biochemical responses of cells to the presence of biomaterials will be monitored in real time and by integrated biosensors. In addition, PANBioRA includes cytotoxicity and genotoxicity tests with microscopic real-time monitoring capacities
BIOMATERIAL TESTING
CELL TESTING
Real-time electrochemical sensing will be used to determine the cellular response to a given biomaterial. A set of cytokines released to the extracellular environment will be used as biomarkers to assess the cell response to different biomaterials.
CELL TESTING
ORGAN ON A CHIP
Respiratory epithelium, gut and liver tissues will be miniaturized into organoids on chip to allow the determination of possible systemic and target organ-specific effects in both healthy and disease conditions.
ORGAN ON A CHIP
SIMULATIONS
SIMULATIONS
Potential risks that are difficult to assess experimentally – such as explosion hazards or full-scale biomaterial/microbiota interactions - will be covered by simulations developed within the project.
Data Analysis
DATA ANALYSIS
The readouts of the modules will be fed into a model developed within PANBioRA using known biocompatible and hazardous materials to provide a quantitative risk assessment.
RISK RATING
RISK RATING
PANBioRA will develop a risk rating system that will display the suitability of the tested biomaterial.

PROJECT NEWS

Share your digital solution on the eHealth Hub Platform to help to manage the healthcare crisis!

Michale Gasik from Aalto University is giving insights in the importance of considering mechanical aspects of biomaterials in order to improve the theraphy's outcome.

Many PANBioRA partners have contributed to the book Biomaterials for Organ and Tissue Regeneration: New Technologies and Future Prospects" to be published end of March.

image credits: www.elveflow.com

Upcoming Events

Open Science for Enhanced Global Environmental Protection

in Glasgow, Scotland

60 countries - 4000 participants - 2400 poster presentations

in Berlin

The MedTech Forum & The Global MedTech Compliance Conference

Latest Tweets